PMC · DOI:10.1016/j.omtn.2025.102557·May 23, 2025
MiR-34 at the crossroads of SMA pathogenesis and therapy: Emerging biomarker and therapeutic target
Jun-An Chen
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNeurogenetic and Muscular Disorders Research · MXene and MAX Phase Materials · Cardiac Structural Anomalies and Repair